Jose Carmona insider trades

Open-market stock purchases and sales by Jose Carmona, Chief Financial Officer at ADC Therapeutics SA, from SEC Form 4 filings since May 15, 2017.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -9%.

Recent trades

DateStockTradeValue
Jun 30, 2026ADCT ADC Therapeutics SABought (not open market)—
Feb 13, 2026ADCT ADC Therapeutics SABought (not open market)$1.1M
Feb 13, 2026ADCT ADC Therapeutics SASold (not open market)$103K
Dec 6, 2025ADCT ADC Therapeutics SASold (not open market)$175K

Companies traded

  • ADCT ADC Therapeutics SA: other filings, last Jun 30, 2026
  • RUBY Rubius Therapeutics, Inc: other filings, last Jan 31, 2022
  • RDUS Radius Health, Inc: 1 buy, 1 sale, last Feb 26, 2020

Get free alerts when Jose Carmona files a new trade →